由耐氟康唑的光滑念珠菌引起的导管相关真菌血症。
Catheter-related fungemia due to fluconazole-resistant Candida nivariensis.
作者信息
Fujita Shin-ichi, Senda Yasuko, Okusi Tikako, Ota Yumi, Takada Hideaki, Yamada Kazunori, Kawano Mitsuhiro
机构信息
Department of Laboratory Medicine, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-8640, Japan.
出版信息
J Clin Microbiol. 2007 Oct;45(10):3459-61. doi: 10.1128/JCM.00727-07. Epub 2007 Jul 25.
Abstract
We report on a case of fungemia due to fluconazole-resistant Candida nivariensis (MIC, > or =128 microg/ml). Internal transcribed spacer PCR followed by microchip gel electrophoresis with a blood culture that tested positive revealed a unique pattern different from those of other pathogenic yeasts.
摘要
我们报告了一例由耐氟康唑的季也蒙念珠菌（MIC≥128μg/ml）引起的真菌血症病例。对一份血培养检测呈阳性的样本进行内部转录间隔区PCR，随后进行微芯片凝胶电泳，结果显示出一种与其他致病性酵母不同的独特图谱。
相似文献
1
Catheter-related fungemia due to fluconazole-resistant Candida nivariensis.
J Clin Microbiol. 2007 Oct;45(10):3459-61. doi: 10.1128/JCM.00727-07. Epub 2007 Jul 25.
2
Catheter-related fungemia caused by Candida intermedia.
Int J Infect Dis. 2010 Feb;14(2):e147-9. doi: 10.1016/j.ijid.2009.03.015. Epub 2009 Jun 3.
3
Outbreak of fungemia among neonates caused by Candida haemulonii resistant to amphotericin B, itraconazole, and fluconazole.
J Clin Microbiol. 2007 Jun;45(6):2025-7. doi: 10.1128/JCM.00222-07. Epub 2007 Apr 11.
4
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
J Antimicrob Chemother. 2008 Dec;62(6):1379-85. doi: 10.1093/jac/dkn381. Epub 2008 Sep 8.
5
A case of Candida lambica fungemia misidentified as Candida krusei in an intravenous drug abuser.
Med Mycol. 2008 Dec;46(8):853-6. doi: 10.1080/13693780802342552.
6
[First case report of catheter-related fungemia by Candida nivariensis in the Iberian Peninsula].
Rev Iberoam Micol. 2013 Jan 3;30(1):69-71. doi: 10.1016/j.riam.2012.09.001. Epub 2012 Sep 14.
7
Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.
Int J Antimicrob Agents. 2008 Mar;31(3):266-71. doi: 10.1016/j.ijantimicag.2007.09.010. Epub 2007 Dec 3.
8
Fluconazole-resistant Kodamaea ohmeri fungemia associated with cellulitis: case report and review of the literature.
Int J Infect Dis. 2009 Nov;13(6):e493-7. doi: 10.1016/j.ijid.2009.02.003. Epub 2009 May 2.
9
[Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report].
Rev Pneumol Clin. 2000 Feb;56(1):37-40.
10
Candida haemulonii and closely related species at 5 university hospitals in Korea: identification, antifungal susceptibility, and clinical features.
Clin Infect Dis. 2009 Mar 15;48(6):e57-61. doi: 10.1086/597108.
引用本文的文献
1
drug resistance genes expression in vulvovaginal candidiasis: a systematic review.
Curr Med Mycol. 2024 Feb 1;10. doi: 10.22034/cmm.2024.345248.1573. eCollection 2024.
2
Enhancing ascitic fungal infection diagnosis through next-generation sequencing: a pilot study in surgical ICU patients.
Front Cell Infect Microbiol. 2024 Nov 1;14:1441805. doi: 10.3389/fcimb.2024.1441805. eCollection 2024.
3
Global Epidemiology of Invasive Infections by Uncommon Species: A Systematic Review.
J Fungi (Basel). 2024 Aug 7;10(8):558. doi: 10.3390/jof10080558.
4
Molecular Epidemiology and Antifungal Susceptibility Profile in Nakaseomyces glabrata Species Complex: A 5-Year Countrywide Study.
J Clin Lab Anal. 2024 May;38(9):e25042. doi: 10.1002/jcla.25042. Epub 2024 May 22.
5
, an emerging fungus causing peritonitis in a patient receiving peritoneal dialysis.
Med Mycol Case Rep. 2022 Dec 5;39:5-7. doi: 10.1016/j.mmcr.2022.11.002. eCollection 2023 Mar.
6
Antifungal Resistance and Virulence Factors, a Perfect Pathogenic Combination.
Pharmaceutics. 2021 Sep 22;13(10):1529. doi: 10.3390/pharmaceutics13101529.
7
First Isolation of Candida nivariensis, an Emerging Fungal Pathogen, in Kuwait.
Med Princ Pract. 2021;30(1):80-84. doi: 10.1159/000511553. Epub 2020 Sep 14.
8
Caenorhabditis elegans as a Model System To Assess Candida glabrata, , and Virulence and Antifungal Efficacy.
Antimicrob Agents Chemother. 2020 Sep 21;64(10). doi: 10.1128/AAC.00824-20.
9
Rapid identification of the Candida glabrata species complex by high-resolution melting curve analysis.
J Clin Lab Anal. 2020 Jun;34(6):e23226. doi: 10.1002/jcla.23226. Epub 2020 Feb 11.
10
Prevalence and Antifungal Susceptibility of the Emerging Fungal Species, , Isolated in a Teaching Hospital in Poland.
Pol J Microbiol. 2019 Sep;68(3):303-308. doi: 10.33073/pjm-2019-032. Epub 2019 Sep 3.
本文引用的文献
1
PCR protocol for specific identification of Candida nivariensis, a recently described pathogenic yeast.
J Clin Microbiol. 2005 Dec;43(12):6194-6. doi: 10.1128/JCM.43.12.6194-6196.2005.
2
Phenotypic and molecular characterization of Candida nivariensis sp. nov., a possible new opportunistic fungus.
J Clin Microbiol. 2005 Aug;43(8):4107-11. doi: 10.1128/JCM.43.8.4107-4111.2005.
3
Rapid identification of staphylococcal strains from positive-testing blood culture bottles by internal transcribed spacer PCR followed by microchip gel electrophoresis.
J Clin Microbiol. 2005 Mar;43(3):1149-57. doi: 10.1128/JCM.43.3.1149-1157.2005.
4
Guidelines for treatment of candidiasis.
Clin Infect Dis. 2004 Jan 15;38(2):161-89. doi: 10.1086/380796. Epub 2003 Dec 19.
5
Multiplex PCR using internal transcribed spacer 1 and 2 regions for rapid detection and identification of yeast strains.
J Clin Microbiol. 2001 Oct;39(10):3617-22. doi: 10.1128/JCM.39.10.3617-3622.2001.
6
Clinical evaluation of the ASTY colorimetric microdilution panel for antifungal susceptibility testing.
J Clin Microbiol. 1998 Sep;36(9):2609-12. doi: 10.1128/JCM.36.9.2609-2612.1998.
Zotero 插件